Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
733 hedge funds and large institutions have $33B invested in Allergan Inc in 2014 Q1 according to their latest regulatory filings, with 88 funds opening new positions, 234 increasing their positions, 301 reducing their positions, and 58 closing their positions.
116% more call options, than puts
Call options by funds: $551M | Put options by funds: $254M
52% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 58
21% more funds holding in top 10
Funds holding in top 10: 29 → 35 (+6)
13% more capital invested
Capital invested by funds: $29.2B → $33B (+$3.79B)
3% more funds holding
Funds holding: 709 → 733 (+24)
22% less repeat investments, than reductions
Existing positions increased: 234 | Existing positions reduced: 301
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$1.45B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$237M |
| 3 |
O
OrbiMed
New York
|
+$182M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$161M |
| 5 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
+$153M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$485M |
| 2 |
VAM
Visium Asset Management
New York
|
-$286M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$166M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$160M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$156M |
AGN Hedge Fund Activity: Q1 2014 in Review
733 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q1 2014, worth a combined $33B — up 13% from $29.2B a quarter earlier.
Buyers outnumbered sellers: 88 funds opened new AGN positions and 58 closed out — a net gain of 30 holders — while 234 added to existing stakes and 301 trimmed.
The largest buyer was Nomura Holdings, adding an estimated $1.45B. The largest seller was Ameriprise, cutting an estimated $485M.
- 733 institutional investors held Allergan Inc (AGN) as of Q1 2014, up from 709 in Q4 2013.
- Funds reported $33B of Allergan Inc stock for Q1 2014, up 13% quarter-over-quarter.
- 88 funds opened new Allergan Inc positions in Q1 2014 and 58 closed out, a net change of +30 holders.
- The largest Allergan Inc buyer in Q1 2014 was Nomura Holdings, an estimated $1.45B added.
- The largest Allergan Inc seller in Q1 2014 was Ameriprise, an estimated $485M sold.
Based on aggregated 13F filings for Q1 2014.